# Néstor Oliva-Dámaso

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/nestor-oliva-damaso/

## Facts

| Field | Value |
| --- | --- |
| Citations | 359 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 9 |
| i10-index | 8 |
| Last Known Institution | Hospital Costa del Sol |
| OpenAlex ID | https://openalex.org/A5035798702 |
| ORCID iD | 0000-0003-0849-1054 |
| Works | 21 |

## Researcher papers

- [Asymmetric (ADMA) and Symmetric (SDMA) Dimethylarginines in Chronic Kidney Disease: A Clinical Approach](https://scholariq.org/papers/asymmetric-adma-and-symmetric-sdma-dimethylarginines-in-chronic-kidney-disease-a/)
- [Lupus Podocytopathy: An Overview](https://scholariq.org/papers/lupus-podocytopathy-an-overview/)
- [Risk-based versus GFR threshold criteria for nephrology referral in chronic kidney disease](https://scholariq.org/papers/risk-based-versus-gfr-threshold-criteria-for-nephrology-referral-in-chronic/)
- [Acute and Chronic Tubulointerstitial Nephritis of Rheumatic Causes](https://scholariq.org/papers/acute-and-chronic-tubulointerstitial-nephritis-of-rheumatic-causes/)
- [Improved nephrology referral of chronic kidney disease patients: potential role of smartphone apps](https://scholariq.org/papers/improved-nephrology-referral-of-chronic-kidney-disease-patients-potential-role/)
- [Glomerular Diseases in Diabetic Patients: Implications for Diagnosis and Management](https://scholariq.org/papers/glomerular-diseases-in-diabetic-patients-implications-for-diagnosis-and/)
- [Rituximab Is Preferable to Cyclophosphamide for Treatment of Membranous Nephropathy: PRO](https://scholariq.org/papers/rituximab-is-preferable-to-cyclophosphamide-for-treatment-of-membranous/)
- [Spot Urinary Sodium as a Biomarker of Diuretic Response in Acute Heart Failure](https://scholariq.org/papers/spot-urinary-sodium-as-a-biomarker-of-diuretic-response-in-acute-heart-failure/)
- [Impact of a phone app on nephrology referral](https://scholariq.org/papers/impact-of-a-phone-app-on-nephrology-referral/)
- [Asymmetric Dimethylarginine (ADMA) Levels Are Lower in Hemodialysis Patients Treated With Paricalcitol](https://scholariq.org/papers/asymmetric-dimethylarginine-adma-levels-are-lower-in-hemodialysis-patients/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Renal and Vascular Pathologies](https://scholariq.org/topics/renal-and-vascular-pathologies/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)

## Researcher university

- [Hospital Costa del Sol](https://scholariq.org/institutions/hospital-costa-del-sol/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.